IMDX vs MAS · rev $271.0K vs P/E 18, rev $7.56B
Insight Molecular Diagnostics Inc. (IMDX) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
IMDX currently screens at market cap $0. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the IMDX and MAS stock pages for the full models.
Not investment advice.